TERNS PHARMACEUTICALS INCTERNS PHARMACEUTICALS INCTERNS PHARMACEUTICALS INC

TERNS PHARMACEUTICALS INC

No trades
See on Supercharts

Price target

17.010.000.00%
The 6 analysts offering 1 year price forecasts for 430 have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to 430 in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


430 EPS for the last quarter is −0.24 EUR despite the estimation of −0.27 EUR. In the next quarter EPS is expected to reach −0.25 EUR. Track more of TERNS PHARMACEUTICALS INC financials and stay on top of what is up with the company.
In the next quarter TERNS PHARMACEUTICALS INC revenue is expected to reach 0.00 EUR. Check out TERNS PHARMACEUTICALS INC revenue and earnings and make informed decisions.
According to analysts, 430 price target is 17.01 EUR with a max estimate of 28.92 EUR and a min estimate of 11.91 EUR. Check if this forecast comes true in a year, meanwhile watch TERNS PHARMACEUTICALS INC stock price chart and keep track of the current situation with 430 news and stock market news.
We've gathered opinions of 8 analysts rating 430 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.